Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies

Abstract

Objective To determine reference values of fetal subcutaneous tissue thickness (SCTT) throughout gestation in

Evaluation of Fetal Growth and Fetal Well-Being

“…Reduced subcutaneous fat mass has been shown in IUGR fetuses and the reduction is more significant when fat is normalized for body size. 41 On the other hand, in gestational diabetes mellitus the increased intrauterine growth is reflected in increased fetal fat mass deposition 42 and intrauterine ultrasound evaluation of fetal fat correlates with fetal leptin levels. 43 …”

Goals of Metabolic Management of Gestational Diabetes

“…However, this approach has not been confirmed by others and has not gained wide popularity. Others suggested that measuring subcutaneous fetal fat tissue (e.g., width/femur length ratio) achieves increased sensitivity and specificity (37)(38)(39)(40)(41). Moreover, assessment of sonographic markers for deviant fetal growth as the width of fetal fat layers, assessment of intraventricular septum width, and abdominal circumference were tested (42).…”

Diagnostic significance of ultrasonographic score in detection of gestational diabetes mellitus

“…Zbog svega toga, ultrazvučna procena adipoznog tkiva je korisna u evaluaciji abnormalnosti fetalnog rasta (Larciprete et al, 2003). Brojne studije izvele su ultrazvučna antropometrijska merenja fetalnog masnog tkiva.…”

“…Brojne studije izvele su ultrazvučna antropometrijska merenja fetalnog masnog tkiva. Među najčešće evaluiranim je merenje masnog tkiva na nivou fetalnog abdomena, a što se izvodi lako i veoma brzo (Larciprete et al, 2003;Melamed et al, 2010). …”

“…Ova doktorska disertacija potvrdila je značajno veću učestalost svih ultrazvučnih markera GDM-a u trudnica kod kojih je ustanovljeno prisustvo ovog patološkog entiteta (p<0.0001), a što je u saglasnosti sa velikim brojem studija koje su se bavile ovom problematikom (Breitweser et al, 1980;Hornberger 2006;Larciprete et al, 2003;Badalian et al, 1996;Zamlynski et al, 2005;Vink et al, 2006;Maulik et al, 2002;Thompson et al, 2002;Bethune et Bell, 2003;Guariglia et al, 2006;Awadh et al, 2006;Merz et Weber, 2005). Među obolelim trudnicama, od svih posmatranih markera najčešće je prisutna placentalna nezrelost, koja se javljala u 88.6% obolelih, a posle nje sledi povećana placentalna debljina sa 79.5% i zadebljani IVS i intenzivirani disajni pokreti koji su bili zastupljeni u 77.3% slučajeva.…”